Virus-specific CD8+ T-cell memory determined by clonal burst size

ALTHOUGH some viruses, particularly the herpes viruses, may never be eliminated from the body1, others like influenza A, regularly reinfect humans and boost waning crossreactive CD8+ T-cell immunity2. Prolonged T-cell memory is found for viruses that are unlikely to be re-encountered and which do not persist in the host genome3–5, indicating that CD8+ T-cell memory might be independent of continued (or sporadic) antigenic exposure. A feature of virus-specific CD8+ T-cell memory is that antigen-specific cytotoxic T-lymphocyte precursors (CTLp) are greatly increased and remain high throughout life. The idea that persistence of the inducing antigen is essential is based on experiments in which adoptively transferred CD8+ memory T cells could not be detected for more than a few weeks in naive recipient mice without secondary challenge6, 7. Here we show that restimulation of such chimaeric mice with an inducing Sendai virus antigen increases the clonal burst size more than 7-fold within 8 days, making memory CTLp easier to detect in the longer term. We find that Sendai-virus-specific CTLp are maintained for >250 days in irradiated unin-fected recipients, including reconstituted β2-microglobulin-/-mice. To determine whether a source of viral peptide can persist after primary infection, we gave Sendai-virus-specific Thyl.l+memory spleen cells to naive mice that had been minimally depleted of Thy 1.2+ T cells, or to comparable recipients that had recovered from infection with Sendai virus or influenza virus. Although antibody against Sendai virus was never found in the naive recipients, Sendai-virus-specific CD8+ memory T cells were maintained equally well in each case for >100 days after cell transfer. We find no evidence for persisting depots of viral protein that might feed into the endogenous processing pathway and maintain viruspecific CD8+ T-cell memory.

[1]  J. Levin,et al.  Synthesis and cellular location of the ten influenza polypeptides individually expressed by recombinant vaccinia viruses. , 1987, Virology.

[2]  R. Zinkernagel,et al.  Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen , 1992, The Journal of experimental medicine.

[3]  R. Jaenisch,et al.  β2-Microglobulin deficient mice lack CD4−8+ cytolytic T cells , 1990, Nature.

[4]  P. Doherty,et al.  Partitioning of responder CD8+ T cells in lymph node and lung of mice with Sendai virus pneumonia by LECAM-1 and CD45RB phenotype. , 1993, Journal of immunology.

[5]  D. Gray,et al.  B-cell memory is short-lived in the absence of antigen. , 1991, Nature.

[6]  M. Eichelberger,et al.  Roles of alpha beta and gamma delta T cell subsets in viral immunity. , 1992, Annual review of immunology.

[7]  G. Ada Strategies in vaccine design. , 1994 .

[8]  A. Müllbacher The long-term maintenance of cytotoxic T cell memory does not require persistence of antigen , 1994, The Journal of experimental medicine.

[9]  D. Conrad,et al.  Follicular dendritic cells and B cell costimulation. , 1993, Journal of immunology.

[10]  A. McMichael,et al.  DECLINING T-CELL IMMUNITY TO INFLUENZA, 1977-82 , 1983, The Lancet.

[11]  P. Holt,et al.  The ELISA-plaque assay for the detection and enumeration of antibody-secreting cells. An overview. , 1986, Journal of immunological methods.

[12]  B. Rocha,et al.  Peripheral T lymphocytes: expansion potential and homeostatic regulation of pool sizes and CD4/CD8 ratios in vivo , 1989, European journal of immunology.

[13]  F. Ennis,et al.  Vaccinia virus-specific CD8+ cytotoxic T lymphocytes in humans , 1993, Journal of virology.

[14]  J. Sprent Lifespans of naive, memory and effector lymphocytes. , 1993, Current opinion in immunology.

[15]  T. Ebels,et al.  DOPAMINE-INDUCED ISCHEMIA , 1977, The Lancet.

[16]  P. Beverley,et al.  Is T-cell memory maintained by crossreactive stimulation? , 1990, Immunology today.

[17]  P. Doherty,et al.  Development and Loss of Virus‐Specific Thymic Competence in Bone Marrow Radiation Chimeras and Normal Mice , 1981, Immunological reviews.

[18]  R. Ahmed,et al.  In vivo selection of lymphocyte-tropic and macrophage-tropic variants of lymphocytic choriomeningitis virus during persistent infection , 1990, Journal of virology.

[19]  P. Doherty,et al.  Immunogenetic analysis of cellular interactions governing the recruitment of T lymphocytes and monocytes in lymphocytic choriomeningitis virus-induced immunopathology. , 1988, Clinical immunology and immunopathology.

[20]  R. Jaenisch,et al.  Delayed clearance of Sendai virus in mice lacking class I MHC-restricted CD8+ T cells. , 1992, Journal of immunology.

[21]  B. Moss,et al.  Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques , 1985, Molecular and cellular biology.

[22]  W. Kast,et al.  Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide. , 1991, Proceedings of the National Academy of Sciences of the United States of America.